Trinity Biotetech公司获得了550万美元的额外资金,延长了付款期限并签发了更多的授权令。 Trinity Biotech secures $5.5M extra funds, extending payment terms and issuing more warrants.

Trinity Biotech是一家诊断公司,它修订了与贷款人感知顾问的协议,增加了550万美元的流动性。 Trinity Biotech, a diagnostics company, has amended its agreements with lender Perceptive Advisors, gaining $5.5 million in additional liquidity. 这包括将500万美元的延期付款延长至2025年,并发出更多的逮捕证。 This includes extending a $5 million deferred payment to 2025 and issuing more warrants. 额外资金将支持该公司的转型计划和发展持续的葡萄糖监测技术,以及帮助世卫组织最近批准的转向低成本制造业。 The extra funds will support the company's transformation plan and development of continuous glucose monitoring technology, as well as help with the recent WHO-approved shift to lower-cost manufacturing.